Skip to content

Effects of Tocomas added to canola oil on oxidative-nitrosative stress parameters, insulin sensitivity and microalbuminuria in type 2 diabetic patients

Effects of Tocomas added to canola oil on oxidative-nitrosative stress parameters, insulin sensitivity and microalbuminuria in type 2 diabetic patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201008092365N2
Enrollment
50
Registered
2010-08-28
Start date
2010-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-insulin-dependent diabetes mellitus. Malnutrition-related diabetes mellitus

Interventions

Intervention 1: Tocomas added to canola oil (525 mg Tocomas per 15 gram canola oil), substitution with daily oil consumption, for 8 weeks. Intervention 2: canola oil (15 gram) substitution with daily
Prevention
Tocomas added to canola oil (525 mg Tocomas per 15 gram canola oil), substitution with daily oil consumption, for 8 weeks
canola oil (15 gram) substitution with daily oil consumption, for 8 weeks

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being volunteer or Wishing to attend, 35-60 y old, diagnosed with type 2 diabetes for at least 1 year (FPG = 126 mg/dl or 2hPG = 200 mg/dl), BMI = 40 kg/m2, no cancer or thyroid or liver disease Exclusion criteria: Taking insulin, Changing medication dosage or physical activity level 2 mo before or during the study, Pregnancy, lactation, dialysis, Using multivitamins, minerals, or other antioxidants during 1 month prior to the study, Using warfarins or other anticoagulant drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Increase Total Antioxidant Capacity (TAC). Timepoint: 8 weeks. Method of measurement: Spectrophotometery.;Decrease nitric oxide (NO). Timepoint: 8 weeks. Method of measurement: colorimeter.

Secondary

MeasureTime frame
Fasting Insulin. Timepoint: 8 weeks. Method of measurement: RIA.;HOMA Index. Timepoint: 8 weeks. Method of measurement: Calculation.;High sensitivity C-reactive protein (hs-CRP). Timepoint: 8 weeks. Method of measurement: Immunoturbidimetry.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026